Tropicamide

Chemical structure and pharmacological group

Tropicamide (Tropicamidum) belongs to the group of muscarinic receptor antagonists (anticholinergics), agents that regulate the functions of the peripheral nervous system. Chemically, the drug is a synthetic derivative of tropic acid. Unlike natural alkaloids, it was specifically synthesized to achieve a more controllable and shorter pharmacological effect.

Mechanism of action and pharmacologic effects

The site of drug action is the muscarinic receptors of the smooth muscle structures of the eye. Blockade of these receptors leads to the relaxation of two key muscles:

• Sphincter pupillae (pupillary sphincter). Its relaxation causes pronounced mydriasis (pupil dilation).
• Ciliary muscle. Its blockade leads to tensioning of the zonules of Zinn, flattening of the lens, and the development of cycloplegia (paralysis of accommodation)—the eye is focused for distance vision.

Pharmacokinetics and clinical advantages

The main difference between tropicamide and classical atropine is its short duration of action.

• Onset of action: very rapid, with the effect developing within 5–10 minutes after instillation.
• Peak of cycloplegia: reached in 20–40 minutes.
• Duration: paralysis of accommodation lasts only 1–2 hours, while mydriasis persists for up to 6 hours.

The key advantage of the drug lies precisely in the short duration of cycloplegia. This makes it an ideal diagnostic tool, as the patient quickly returns to normal life without prolonged visual impairment.

Comparison with other anticholinergics

Various drugs of this group are used in ophthalmology, and the choice depends on the required duration of effect:

• Atropine—has an extremely prolonged action, causing prolonged discomfort for the patient.
• Cyclopentolate—causes effects similar to tropicamide, but differs in a significantly longer duration of action (20–24 hours). It is used for refraction testing in young children and for short-term diagnostic procedures.
• Homatropine—a synthetic substance (an ester of tropine and mandelic acid, a tertiary amine). It is similar in properties to atropine, but has lower activity and a shorter duration of action (15–20 hours).
• Scopolamine—a natural alkaloid with an epoxide bridge. Unlike atropine ($pK_a = 9.0$), scopolamine has a $pK_a = 7.2$, therefore at physiological plasma pH it is predominantly in the un ionized (lipophilic) state and easily crosses the blood-brain barrier (BBB). Tropicamide, on the other hand, is used strictly topically.

Indications for use

In clinical practice, tropicamide is used primarily for fundus examination (ophthalmoscopy), where a wide pupil is required for full visual control of the retina, optic disc, and blood vessels.

Side effects and systemic action

Despite topical administration, the drug can exert systemic anticholinergic effects. This occurs due to the absorption of the active substance into the systemic bloodstream through the mucosa of the lacrimal duct.

• Systemic symptoms: tachycardia, dry mouth, headache.
• Local symptoms: photophobia (light sensitivity) due to a wide pupil that does not react to light.
• Pediatric consideration: in children, there is a high risk of developing hyperthermia against the background of systemic drug absorption.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Comparative pharmacokinetics of anticholinergics (atropine, scopolamine, cyclopentolate).
• Mechanism of development of systemic side effects during eye drop instillation.
• Physiology of accommodation and the role of the ciliary muscle.
• Pathogenesis of angle-closure glaucoma and the effect of mydriatics on intraocular pressure.
• Specifics of using anticholinergics in pediatric practice.

Other topics in the «Drugs and Prescriptions» section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.